Seelos Therapeutics Inc (SEEL)

[RVL]

DG,
Social is correct.
I believe the demand for the drug by physicians and/or patients has resulted in Vitaros being added to commercial Formularies.
This is ABSOLUTELY great. It really shows me Takeda is doing their job.
This takes a product that can only be accessed through cash money, to one that is covered typically with a co-pay or co-insurance.
For those of you with commercial insurance, think of drugs you use.
If a "life style" drug and is not on formulary, you are VERY unlikely to use because of cost. If drug is on formulary, if you are aware of drug and formulary status, you would likely request prescription for drug from your physician.
If not on formulary, you and/or you physician would petition to add to formulary.
I am VERY pleased that Takeda has obviously worked hard to put us in this position and am even happier that I bought more APRI around $2.00.
RVL